default author photo

Tae-Joong Kim

Sungkyunkwan University - Samsung Medical Center

81, Irwon- Ro

Gangnam-gu

Seoul, 135-710

Korea, Republic of (South Korea)

SCHOLARLY PAPERS

1

DOWNLOADS

40

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Efficacy and Safety of Pembrolizumab With or Without Lenvatinib in Recurrent Uterine Carcinosarcoma: a Real-World Single-Center Study

Number of pages: 25 Posted: 01 Oct 2025
Sungkyunkwan University - Samsung Medical Center, Sungkyunkwan University - Samsung Medical Center, Sungkyunkwan University - Samsung Medical Center, Sungkyunkwan University School of Medicine, Sungkyunkwan University - Samsung Medical Center, Sungkyunkwan University - Samsung Medical Center, Sungkyunkwan University - Department of Obstetrics and Gynecology and Sungkyunkwan University - Samsung Medical Center
Downloads 40 (1,236,159)

Abstract:

Loading...

Uterine carcinosarcoma, Recurrent endometrial cancer, Immunotherapy, Pembrolizumab, Real-world data